Jump Financial’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-25,492
Closed -$33.6K 2349
2026
Q1
$33.6K Sell
25,492
-8,254
-24% -$14.8K ﹤0.01% 1798
2025
Q4
$63.1K Buy
+33,746
New +$64.8K ﹤0.01% 1859
2025
Q3
Sell
-11,900
Closed -$14.8K 2105
2025
Q2
$14.8K Sell
11,900
-9,513
-44% -$11K ﹤0.01% 1742
2025
Q1
$25.3K Buy
+21,413
New +$32.8K ﹤0.01% 1536
2024
Q1
Sell
-15,092
Closed -$148K 2193
2023
Q4
$148K Sell
15,092
-380,111
-96% -$3.11M ﹤0.01% 1618
2023
Q3
$3.3M Buy
395,203
+274,582
+228% +$3.14M 0.12% 207
2023
Q2
$1.6M Sell
120,621
-22,890
-16% -$278K 0.06% 465
2023
Q1
$1.66M Buy
+143,511
New +$1.43M 0.07% 412
2022
Q3
Sell
-230,813
Closed -$1.02M 1855
2022
Q2
$1.02M Buy
230,813
+11,975
+5% +$72.8K 0.04% 560
2022
Q1
$1.99M Buy
218,838
+129,504
+145% +$1.49M 0.08% 284
2021
Q4
$1.83M Buy
89,334
+56,626
+173% +$1.37M 0.11% 229
2021
Q3
$835K Buy
+32,708
New +$969K 0.06% 337
2021
Q2
Sell
-61,900
Closed -$2.06M 1317
2021
Q1
$2.06M Buy
+61,900
New +$2.17M 0.19% 90

Other funds holding PACB

Jump Financial's PACB Position: Q2 2026 in Review

Jump Financial sold out of Pacific Biosciences (PACB) in Q2 2026, closing a stake of 25,492 shares — an estimated $33.6K sold.

Jump Financial first reported a position in PACB in Q1 2021 and held it in 13 quarters. The position peaked at $3.3M in Q3 2023. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Jump Financial reported no remaining Pacific Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 25,492 Pacific Biosciences shares in Q2 2026, an estimated $33.6K.
  • Jump Financial first reported a position in Pacific Biosciences in Q1 2021 and held it in 13 quarters.
  • Jump Financial's Pacific Biosciences position peaked at $3.3M in Q3 2023.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.